Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Antispasmodics Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High incidences of irritable bowel syndrome and abdominal problems
5.1.1.2. Increasing patient awareness level and improvement in treatment
5.1.1.3. Rising antispasmodic medicines approvals worldwide
5.1.2. Restraints
5.1.2.1. Patent expiration issues of antispasmodic drugs
5.1.3. Opportunities
5.1.3.1. Growing investment in research and development of novel antispasmodic meds
5.1.3.2. Investment and expansion of generic drugs production facilities
5.1.4. Challenges
5.1.4.1. Inappropriate use of skeletal muscle relaxants in geriatric patients
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Antispasmodics Drugs Market, by Drug type
6.1. Introduction
6.2. Dicyclomine Hydrochloride
6.3. Hyoscyamine
6.4. Loperamide Hydrochloride

7. Antispasmodics Drugs Market, by Route of administration
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Sublingual

8. Antispasmodics Drugs Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy

9. Antispasmodics Drugs Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Speciality Centres

10. Americas Antispasmodics Drugs Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Antispasmodics Drugs Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Antispasmodics Drugs Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Actiza Pharmaceutical Private Limited
14.1.2. Ambrosia Pharma
14.1.3. Amneal Pharmaceuticals LLC
14.1.4. Aurobindo Pharma Limited
14.1.5. B JOSHI AGROCHEM PHARMA
14.1.6. Blue Cross Laboratories Pvt Ltd.
14.1.7. Daiichi Sankyo Company, Limited
14.1.8. Dr. Reddys Laboratories Ltd.
14.1.9. Flamingo Pharmaceuticals Ltd
14.1.10. Fresenius Kabi AG
14.1.11. GlaxoSmithKline PLC
14.1.12. Hikma Pharmaceuticals PLC
14.1.13. Johnsons & Johnsons Services Inc.
14.1.14. Lexicare Pharma Pvt. Ltd.
14.1.15. McKesson Medical-Surgical Goverment Solutions LLC
14.1.16. Mylan N.V.
14.1.17. Nexus Pharmaceuticals Inc.
14.1.18. Noreva Biotech
14.1.19. Pfizer Inc.
14.1.20. Sanofi SA
14.1.21. Solitaire Pharmacia Private Limited
14.1.22. Strides Pharma Science Limited
14.1.23. Sun Pharmaceutical Industries Ltd.
14.1.24. Takeda Pharmaceutical Company Limited
14.1.25. Wellona Pharma Private Limited
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. ANTISPASMODICS DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTISPASMODICS DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. ANTISPASMODICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ANTISPASMODICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ANTISPASMODICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ANTISPASMODICS DRUGS MARKET DYNAMICS
FIGURE 7. ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 10. ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ANTISPASMODICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ANTISPASMODICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ANTISPASMODICS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ANTISPASMODICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTISPASMODICS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 6. ANTISPASMODICS DRUGS MARKET SIZE, BY DICYCLOMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ANTISPASMODICS DRUGS MARKET SIZE, BY HYOSCYAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ANTISPASMODICS DRUGS MARKET SIZE, BY LOPERAMIDE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 10. ANTISPASMODICS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ANTISPASMODICS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ANTISPASMODICS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. ANTISPASMODICS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ANTISPASMODICS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ANTISPASMODICS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. ANTISPASMODICS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ANTISPASMODICS DRUGS MARKET SIZE, BY SPECIALITY CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. CANADA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. MEXICO ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. MEXICO ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ANTISPASMODICS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. CHINA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CHINA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. INDIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. INDIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. JAPAN ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. JAPAN ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. THAILAND ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. THAILAND ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. DENMARK ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. DENMARK ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. EGYPT ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EGYPT ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. FINLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. FINLAND ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. FRANCE ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. GERMANY ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. ITALY ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. NORWAY ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. NORWAY ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. POLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. POLAND ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. QATAR ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. QATAR ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. SPAIN ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. TURKEY ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. TURKEY ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM ANTISPASMODICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ANTISPASMODICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM ANTISPASMODICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ANTISPASMODICS DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. ANTISPASMODICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. ANTISPASMODICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. ANTISPASMODICS DRUGS MARKET LICENSE & PRICING